Perez v. Progenics Pharmaceuticals, Inc. et al, No. 1:2010cv08278 - Document 318 (S.D.N.Y. 2016)

Court Description: OPINION re: 262 FIRST MOTION for Attorney Fees (refiled), filed by Christopher P Keenan, 265 MOTION for New Trial, MOTION to Alter Judgment re: 250 Clerk's Judgment, filed by Progenics Pharmaceut icals, Inc; 257 MOTION for an Order granting prejudgment interest, filed by Julio Perez, 259 MOTION Plaintiff's Reinstatement, filed by Julio Perez. Accordingly, the Court denies Defendant's motion for remittitur. The previously-entered judgment (ECF No. 250) is withdrawn. For the foregoing reasons, Plaintiff's motion for prejudgment interest (ECF No. 257) is granted. The parties shall re-calculate prejudgment interest through September 9, 2016 (or the ne arest month end), consistent with the resolutions herein, and submit those re-calculations no later than September 8. Plaintiff's motion for reinstatement (ECF No. 259) is granted as to his front pay claim in the amount of $2,706,585.0 0. The motion by Plaintiff's former counsel, Westermann, Sheehy, Keenan, Samaan, & Aydelott, LLP, for attorney's fees (ECF No. 262) is denied in part as to the attorney's fees and granted in part as to leave to renew its motion for a charging lien, provided that the motion is filed no later than September 9. The Court will allow Plaintiff ten days from the Court's entry of a charging lien to file his motion for attorney's fees. Defendant's motion for a new trial or, in the alternative, for remittitur (ECF No. 265) is denied. (As further set forth in this Opinion) (Signed by Judge Loretta A. Preska on 8/30/2016) (kl)

Download PDF
Perez v. Progenics Pharmaceuticals, Inc. et al Doc. 318 Dockets.Justia.com

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.